BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
231 hedge funds and large institutions have $1.7B invested in bluebird bio in 2021 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 81 increasing their positions, 60 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
231
Holders Change
+2
Holders Change %
+0.87%
% of All Funds
4.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
43
Increased
81
Reduced
60
Closed
41
Calls
$26.1M
Puts
$32.6M
Net Calls
-$6.52M
Net Calls Change
+$13.5M
Top Buyers
| 1 |
BlackRock
New York
|
+$61.5M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$25.4M |
| 3 |
Goldman Sachs
New York
|
+$24.2M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$18M |
| 5 |
JPMorgan Chase & Co
New York
|
+$17.1M |
